Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
41
# OF OVERLAPPING
HOLDINGS
FHLC
342
HOLDINGS
13%
ALSO IN CANC
CANC
56
HOLDINGS
73%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.9% | 4.4% | 4.4% |
|
MERCK & CO. INC. | 4.4% | 4.6% | 4.4% |
|
ABBVIE INC | 6.0% | 3.5% | 3.5% |
|
JOHNSON & JOHNSON | 8.6% | 3.2% | 3.2% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% | 3.6% | 1.7% |
FHLC Overweight Relative to CANC
|
ELI LILLY & CO | 9.4% |
|
UNITEDHEALTH GROUP INC | 5.7% |
|
JOHNSON & JOHNSON | 5.4% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% |
|
ABBVIE INC | 2.5% |
|
ABBOTT LABORATORIES | 2.4% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
PFIZER INC | 2.3% |
|
CVS CAREMARK CORP | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
FHLC Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.1% |
|
COGENT BIOSCIENCES INC | -4.9% |
 |
NOVARTIS AG | -3.6% |
|
BEIGENE LTD. SPONSORED ADR | -3.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.1% |
 |
GENMAB A/S SPONSORED ADR | -2.9% |
|
HALOZYME THERAPEUTICS INC | -2.9% |
|
IMMUNOME, INC. | -2.8% |
|
CG ONCOLOGY, INC. | -2.7% |
|
EXELIXIS INC | -2.6% |